METAFORA biosystems METAFORA biosystems develops a unique technology based on new biomarkers nutrients transporters ligands, allowing identifying and measuring the changes in the metabolic status of living cells in normal or disrupted conditions by illness or a drug. This technology has a great number of competitive advantages in several segments of the market of biomarkers. We propose an innovative chronic toxicity assay and a drug discovery signature targeting cancer cell metabolism Please read our detailed offer leaflet following the link bellow :  http://metafora-biosystems.com/images/lesPdfs/Bus%20Dev%20METAFORA%20biosystems%20150113F%20com.pdf